Genome British Columbia Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 2
Professionals
  • Investments
  • 17
  • Portfolio
  • 13
  • Exits
  • 2
Exits

Genome British Columbia General Information

Description

Founded in 2000, Genome British Columbia is a not-for-profit venture capital firm based in Vancouver, Canada. The firm seeks investments in early stage companies. The firm prefers to make investments in research, entrepreneurship, life sciences, health, forestry, fisheries, aquaculture, agri-food, energy, mining and environmental sectors.

Contact Information

Website
Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Not-For-Profit Venture Capital
Primary Office
  • Suite 400-575
  • West 8th Avenue
  • Vancouver, British Columbia V5Z 0C4
  • Canada
+1 (604) 000-0000

Genome British Columbia Investments (17)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Alavida 30-Jun-2020 Later Stage VC Outcome Management (Healthcare) Generating Revenue
000000000000 02-Jun-2020 00000 00000 00000 Diagnostic Equipment Generating Revenue
00000 0000000 28-May-2020 0000 00000 00.00 Diagnostic Equipment Generating Revenue 0000 000000 00.0
00000 000000000000 30-Sep-2019 00000 00000 000 Electronics (B2C) Generating Revenue
000000000000 24-Apr-2019 00000 00000 00.00 Diagnostic Equipment Generating Revenue
0000000000 0000000 09-Apr-2018 00000 00000 00.00 Laboratory Services (Healthcare) Generating Revenue
000000 0000000000 15-Mar-2018 00000 00000 00000 Biotechnology Generating Revenue
0000000 0000000000 10-Nov-2017 0000 00000 00.00 Monitoring Equipment Generating Revenue
Augurex 25-Jan-2017 Later Stage VC Diagnostic Equipment Generating Revenue
ViewsIQ 01-Oct-2016 Later Stage VC 00000 Laboratory Services (Healthcare) Generating Revenue 000000 0000000000
You’re viewing 10 of 17 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genome British Columbia Exits (2)

Company Name Exit Date Exit Type Exit Size
Cyon Therapuetics 01-May-2019 Out of Business
0000000 14-Aug-2018 000000000000000000 000.00
To view Genome British Columbia’s complete exits history, request access »

Genome British Columbia Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Genome British Columbia Team (10)

Name Title Deals Funds Boards Office
Pascal Spothelfer Chief Executive Officer & President 0 Vancouver, Canada
Tony Brooks Ph.D Chief Financial Officer & Vice President, Entrepreneurship & Commercialization 0 Vancouver, Canada
Federica Palma Ph.D Chief Scientific Officer & Vice President of Sectors Vancouver, Canada
Pat Brady Director, Industry Innovation Programs Vancouver, Canada
Sally Greenwood Vice President, Communications and Societal Engagement Vancouver, Canada
You’re viewing 5 of 10 team members. Get the full list »

Genome British Columbia Co-Investors (17)

Name With Exits Lead Partner Series Industry
E-Fund 2 0 Series chart Industry bar
Boardwalk 0 Series chart Industry bar
Right Side Capital Management 0 Series chart Industry bar
Small World Group 0 0 Series chart Industry bar
UBC Seed Fund 0 0 Series chart Industry bar
You’re viewing 5 of 17 co-investors. Get the full list »